Bixiye
QP109-18 Medicare Advantage Implementation Frequently Asked Questions (FAQ)
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Natiijooyinka Raadinta
Soo bandhiga 2851 - 2860 ee natiijooyinka 4130
Bixiye
QP108-18 FEP Blue Focus Members
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
QP107-18 Pharmacy Update - Medicare Part D Opioid Drug Management Programs
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
QP105-18 InterQual Level of Care Criteria for Authorizations
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
QP104-18 Claims Processing Issues Grid
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
QP102-18 Update: Change in Medical Drug Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
QP103-18 Quality Improvement Information
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
QP101-18 Pharmacy Update for Praluent (alirocumab) and Repatha (evolocumab)
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2018
Bixiye
2018 December Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Des 03, 2018
Bixiye
QP97-18 Withdraw Feature Available for Availity Authorizations
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018